Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:
   

China Cord Blood Modifies Terms for Warrants

publication date: Sep 13, 2010
China Cord Blood Corporation said it will offer holders of warrants the opportunity to exchange one ordinary share for every eight warrants. The warrants are due to expire on December 13, 2010, just three months from now. At present, each warrant entitles the holder to buy one share at $5. No financial terms were announced. As China Cord Blood’s shares are currently trading at $4, close to a year-low, the warrants do not have much value currently. More details....

Stock Symbol: (NYSE: CO)


Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes


Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital